TFF PharmaceuticalsTFFP
13F holders, Q1 2025 (March 31)3holders −1
1new positions
2sold out
$0.00avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($0), Farther Finance Advisors, LLC ($0) and Gen-Wealth Partners Inc ($0).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 2 | $196 |
All 13F filers, Q4 2024 → Q1 2025: 15 shares bought and 3,550 shares sold, net −3,535 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| DRW Securities, LLC | 0.00% | No change | 40,000 | $0 |
| Farther Finance Advisors, LLC | 0.00% | New | 15 | $0 |
| Gen-Wealth Partners Inc | 0.00% | No change | 100 | $0 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.